Position history for Equitable Holdings, Inc.'s holdings in ImmunityBio, Inc.
Equitable Holdings, Inc. holds 15,925 shares of IBRX (ImmunityBio, Inc.), worth $31,532 as of 2025-Q4. The position was increased (++2.7% shares). IBRX represents 0.0% of Equitable Holdings, Inc.'s portfolio.
Current Value
$31,532
Current Shares
15,925
Total Value Change
-$6,748
Total Shares Change
+1,425
Other major holders of IBRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 15,925 |
+2.7% |
| $31,532 |
| 0.0% |
| $1.98 |
20 |
| 2025-Q3 | Increased | 15,500 | +6.9% | $38,130 | 0.0% | $2.57 | 21 |
| 2025-Q2 | New | 14,500 | - | $38,280 | 0.0% | $2.70 | 28 |